Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anu Mohan Desai"'
Autor:
Benzeeta Pinto, Anu Mohan Desai, Farha Furruqh, K N Sangeeta, B Sheba Charles, John Michael Raj, Ramya Janardana, Vineeta Shobha
Publikováno v:
Indian Journal of Rheumatology, Vol 16, Iss 2, Pp 204-208 (2021)
Introduction: Chikungunya fever is a remerging disease and may lead to postchikungunya inflammatory joint pain. Objective: To study the clinical and ultrasound (US) features of chikungunya arthritis in the subacute phase and to determine if high dise
Externí odkaz:
https://doaj.org/article/ef686b927d494250a9d4a9d6b1f66f96
Autor:
Vineeta Shobha, Vijay Rao, Anu Mohan Desai, Ramesh Jois, Chandrashekara Srikantiah, B G Dharmanand, Sharath Kumar, Pradeep Kumar, Chethana Dharmapalaiah, K M Mahendranath, Shiva Prasad, Manisha Daware, Yogesh Singh, Uma Karjigi
Publikováno v:
Indian Journal of Rheumatology, Vol 14, Iss 1, Pp 17-20 (2019)
Introduction: Biologics are widely used in Autoimmune rheumatologic diseases (AIRDs), however the need to capture real life data which monitors indications, adverse reactions cannot be over emphasized. Methods: This is a cross-sectional ambidirection
Externí odkaz:
https://doaj.org/article/671fc135aa864d58b54f65e2ba1ab678
Autor:
BG Dharmanand, Shiva Prasad, Krishnamurthy Anupama, Anu Mohan Desai, Vijay Rao, Uma Karjigi, Manisha Ashwin Daware, Yogesh Preet Singh, S Chandrashekara, Kurugodu Mathada Mahendranath, Vineeta Shobha, Pradeep Kumar, Sharath Kumar, Ramesh Jois, Santosh Nagaraj, Chethana Dharmapalaiah
Publikováno v:
Rheumatology International. 39:497-507
Biologic disease-modifying anti-rheumatic drugs (bDMARD) have transformed the treatment paradigm of chronic autoimmune rheumatic diseases (ARDs), but they are often associated with adverse drug reactions. The present study evaluated the frequency, ch
Autor:
Vijay Rao, Chandrashekara Srikantiah, Yogesh Preet Singh, Pradeep Kumar, Sharath Kumar, Vineeta Shobha, Anu Mohan Desai, BG Dharmanand, Uma Karjigi, Chethana Dharmapalaiah, Shiva Prasad, Manisha Ashwin Daware, Kurugodu Mathada Mahendranath, Ramesh Jois
Publikováno v:
Indian Journal of Rheumatology, Vol 14, Iss 1, Pp 17-20 (2019)
Introduction: Biologics are widely used in Autoimmune rheumatologic diseases (AIRDs), however the need to capture real life data which monitors indications, adverse reactions cannot be over emphasized. Methods: This is a cross-sectional ambidirection
Autor:
B Sheba Charles, Ramya Janardana, John Michael Raj, KN Sangeeta, Anu Mohan Desai, Farha Furruqh, Benzeeta Pinto, Vineeta Shobha
Publikováno v:
Indian Journal of Rheumatology, Vol 16, Iss 2, Pp 204-208 (2021)
Introduction: Chikungunya fever is a remerging disease and may lead to postchikungunya inflammatory joint pain. Objective: To study the clinical and ultrasound (US) features of chikungunya arthritis in the subacute phase and to determine if high dise
Autor:
Vijay Rao, Kurugodu Mathada Mahendranath, Yogesh Preet Singh, Manisha Ashwin Daware, Uma Karjigi, Krishnamurthy Anupama, S Chandrashekara, Anu Mohan Desai, BG Dharmanand, Pradeep Kumar, Vineeta Shobha, Chethana Dharmapalaiah, Shiva Prasad, S. Nagaraj, Ramesh Jois, Sharath Kumar
Publikováno v:
International journal of rheumatic diseases. 22(2)
Aim Tuberculosis (TB) is one of the major adverse events of concern associated with the use of biologics for managing autoimmune inflammatory rheumatic diseases (AIRDs). The study presents the data on incidence of TB in relation to biologic used, scr